{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:53:42Z","timestamp":1775483622525,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Infective endocarditis (IE) is associated with a\u00a0high in-hospital and long term mortality. Although progress has been made in diagnostic approach and management of IE, morbidity and mortality of IE remain high. In the latest European guidelines, the importance of the multi-modality imaging in diagnosis and follow up of IE is emphasized.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Aim<\/jats:title>\n<jats:p>The aim was to provide information regarding mortality and adverse events of IE, to determine IE characteristics and to assess current use of imaging in the diagnostic workup of IE.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This is a\u00a0prospective observational cohort study. We used data from the EURO-ENDO registry. Seven hospitals in the Netherlands have participated and included patients with IE between April 2016 and April 2018.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A\u00a0total of 139 IE patients were included. Prosthetic valve endocarditis constituted 32.4% of the cases, cardiac device related IE 7.2% and aortic root prosthesis IE 3.6%. In-hospital mortality was 14.4% (20\u00a0patients) and one-year mortality was 21.6% (30\u00a0patients). The incidence of embolic events under treatment was 16.5%, while congestive heart failure or cardiogenic shock occurred in 15.1% of the patients. Transthoracic and transoesophageal echocardiography were performed most frequently (97.8%; 81.3%) and within 3\u00a0days after IE suspicion, followed by <jats:sup>18<\/jats:sup>F\u2011fluorodeoxyglucose positron emission tomography\/computed tomography (45.3%) within 6\u00a0days and multi-slice computed tomography (42.4%) within 7\u00a0days.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We observed a\u00a0high percentage of prosthetic valve endocarditis, rapid and extensive use of imaging and a\u00a0relatively low in-hospital and one-year mortality of IE in the Netherlands. Limitations include possible selection bias.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s12471-020-01431-z","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T09:02:21Z","timestamp":1591347741000},"page":"526-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Infective endocarditis in the Netherlands: current epidemiological profile and mortality"],"prefix":"10.1007","volume":"28","author":[{"given":"S.","family":"El Kadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M. F.","family":"van den Buijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Gilbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C. A. M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"van Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. K.","family":"Riezebos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. L.","family":"Blok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Tanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Wahadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Roos-Hesselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. I. G.","family":"van der Spoel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A. J.","family":"Chamuleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"EURO ENDO Investigators group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","volume":"169","author":"DR Murdoch","year":"2009","unstructured":"Murdoch\u00a0DR, Corey\u00a0GR, Hoen\u00a0B. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009;169:463\u201373.","journal-title":"Arch Intern Med"},{"key":"1431_CR2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jama.1985.03360090089026","volume":"254","author":"MR Griffin","year":"1985","unstructured":"Griffin\u00a0MR, Wilson\u00a0WR, Edwards\u00a0WD, O\u2019Fallon\u00a0WM, Kurland\u00a0LT. Infective endocarditis. JAMA. 1985;254:1199.","journal-title":"JAMA"},{"key":"1431_CR3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehl427","volume":"28","author":"EE Hill","year":"2007","unstructured":"Hill\u00a0EE, Herijgers\u00a0P, Claus\u00a0P, Vanderschueren\u00a0S, Herregods\u00a0MC, Peetermans\u00a0WE. Infective endocarditis: changing epidemiology and predictors of 6\u2011month mortality: a prospective cohort study. Eur Heart\u00a0J. 2007;28:196\u2013203.","journal-title":"Eur Heart J"},{"key":"1431_CR4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","volume":"58","author":"AJ Greenspon","year":"2011","unstructured":"Greenspon\u00a0AJ, Patel\u00a0JD, Lau\u00a0E, Ochoa\u00a0J, Frisch\u00a0DR, Ho\u00a0RT, et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J\u00a0Am Coll Cardiol. 2011;58:1001\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1431_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ehjqcco\/qcw039","volume":"3","author":"FS van den Brink","year":"2017","unstructured":"van den Brink\u00a0FS, Swaans\u00a0MJ, Hoogendijk\u00a0MG, Alipour\u00a0A, Kelder\u00a0JC, Jaarsma\u00a0W, et\u00a0al. Increased incidence of infective endocarditis after the 2009 European society of cardiology guideline update: a nationwide study in the Netherlands. Eur Heart J Qual Care Clin Outcomes. 2017;3(2):141\u20137. https:\/\/doi.org\/10.1093\/ehjqcco\/qcw039.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"1431_CR6","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"G Habib","year":"2009","unstructured":"Habib\u00a0G, Hoen\u00a0B, Tornos\u00a0P, Thuny\u00a0F, Prendergast\u00a0B, Vilacosta\u00a0I, et\u00a0al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Eur Heart\u00a0J. 2009;30:2369\u2013413.","journal-title":"Eur Heart J"},{"issue":"44","key":"1431_CR7","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib\u00a0G, Lancellotti\u00a0P, Antunes\u00a0MJ, Bongiorni\u00a0MG, Casalta\u00a0JP, Del Zotti\u00a0F, et\u00a0al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart\u00a0J. 2015;36(44):3075.","journal-title":"Eur Heart J"},{"issue":"23","key":"1431_CR8","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2013.01.092","volume":"61","author":"L Saby","year":"2013","unstructured":"Saby\u00a0L, Laas\u00a0O, Habib\u00a0G, Cammilleri\u00a0S, Mancini\u00a0J, Tessonnier\u00a0L, et al. Positron emission tomography\/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a\u00a0novel major criterion. J\u00a0Am Coll Cardiol. 2013;61(23):2374\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1431_CR9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archinternmed.2009.192","volume":"169","author":"E Botelho-Nevers","year":"2009","unstructured":"Botelho-Nevers\u00a0E, Thuny\u00a0F, Casalta\u00a0JP, Richet\u00a0H, Gouriet\u00a0F, Collart\u00a0F, et al. Dramatic reduction in infective endocarditis\u2014related mortality with a\u00a0management-based approachreduction in infective endocarditis mortality. JAMA Intern Med. 2009;169(14):1290\u20138.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1431_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.recesp.2013.09.012","volume":"67","author":"F Carrasco-Chinchilla","year":"2014","unstructured":"Carrasco-Chinchilla\u00a0F, Sanchez-Espin\u00a0G, Ruiz-Morales\u00a0J, Rodriguez-Bailon\u00a0I, Melero-Tejedor\u00a0JM, Ivanova-Georgieva\u00a0R, et al. Influence of a\u00a0multidisciplinary alert strategy on mortality due to left-sided infective endocarditis. Rev Esp Cardiol (Engl Ed). 2014;67(5):380\u20136.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"1431_CR11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(11)60755-1","volume":"379","author":"F Thuny","year":"2012","unstructured":"Thuny\u00a0F, Grisoli\u00a0D, Collart\u00a0F, Habib\u00a0G, Raoult\u00a0D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965\u201375.","journal-title":"Lancet"},{"key":"1431_CR12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/archinte.1992.00400210093015","volume":"152","author":"JTM van der Meer","year":"1992","unstructured":"van der Meer\u00a0JTM, Thompson\u00a0J, Valkenburg\u00a0HA, Michel\u00a0MF. Epidemiology of bacterial endocarditis in the Netherlands. Arch Intern Med. 1992;152:1869.","journal-title":"Arch Intern Med"},{"key":"1431_CR13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12471-015-0743-0","volume":"23","author":"MMG Krul","year":"2015","unstructured":"Krul\u00a0MMG, Vonk\u00a0ABA, Cornel\u00a0JH. Trends in incidence of infective endocarditis at the medical center of Alkmaar. Neth Heart\u00a0J. 2015;23:548\u201354.","journal-title":"Neth Heart J"},{"key":"1431_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/cdt.2016.08.09","volume":"7","author":"A Cresti","year":"2017","unstructured":"Cresti\u00a0A, Chiavarelli\u00a0M, Scalese\u00a0M, Nencioni\u00a0C, Valentini\u00a0S, Guerrini\u00a0F, et al. Epidemiological and mortality trends in infective endocarditis, a\u00a017-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7:27\u201335.","journal-title":"Cardiovasc Diagn Ther"},{"key":"1431_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0067519","volume":"8","author":"A Ternhag","year":"2013","unstructured":"Ternhag\u00a0A, Cederstr\u00f6m\u00a0A, T\u00f6rner\u00a0A, Westling\u00a0K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8:1\u20137.","journal-title":"PLoS One"},{"key":"1431_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(03)15266-X","volume":"363","author":"P Moreillon","year":"2004","unstructured":"Moreillon\u00a0P, Que\u00a0Y\u2011A. Infective endocarditis. Lancet. 2004;363:139\u201349.","journal-title":"Lancet"},{"issue":"6","key":"1431_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM199608083350607","volume":"335","author":"W Vongpatanasin","year":"1996","unstructured":"Vongpatanasin\u00a0W, Hillis\u00a0LD, Lange\u00a0RA. Prosthetic heart valves. N\u00a0Engl J Med. 1996;335(6):407\u201316.","journal-title":"N Engl J Med"},{"issue":"14","key":"1431_CR18","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.118.035032","volume":"138","author":"LE Swart","year":"2018","unstructured":"Swart\u00a0LE, Gomes\u00a0A, Scholtens\u00a0AM, Sinha\u00a0B, Tanis\u00a0W, Lam\u00a0M, et al. Improving the diagnostic performance of (18)F-fluorodeoxyglucose positron-emission tomography\/computed tomography in prosthetic heart valve endocarditis. Circulation. 2018;138(14):1412\u201327.","journal-title":"Circulation"},{"issue":"26","key":"1431_CR19","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","volume":"366","author":"DH Kang","year":"2012","unstructured":"Kang\u00a0DH, Kim\u00a0YJ, Kim\u00a0SH, Sun\u00a0BJ, Kim\u00a0DH, Yun\u00a0SC, et\u00a0al. Early surgery versus conventional treatment for infective endocarditis. N\u00a0Engl J Med. 2012;366(26):2466\u201373.","journal-title":"N Engl J Med"},{"issue":"8","key":"1431_CR20","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.STR.0000229894.28591.3f","volume":"37","author":"E Ruttmann","year":"2006","unstructured":"Ruttmann\u00a0E, Willeit\u00a0J, Ulmer\u00a0H, Chevtchik\u00a0O, Hofer\u00a0D, Poewe\u00a0W, et\u00a0al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37(8):2094\u20139.","journal-title":"Stroke"},{"issue":"8","key":"1431_CR21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.amjcard.2013.05.060","volume":"112","author":"F Chirillo","year":"2013","unstructured":"Chirillo\u00a0F, Scotton\u00a0P, Rocco\u00a0F, Rigoli\u00a0R, Borsatto\u00a0F, Pedrocco\u00a0A, et\u00a0al. Impact of a\u00a0multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol. 2013;112(8):1171\u20136.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1431_CR22","doi-asserted-by":"publisher","first-page":"e000699","DOI":"10.1136\/openhrt-2017-000699","volume":"4","author":"A Kaura","year":"2017","unstructured":"Kaura\u00a0A, Byrne\u00a0J, Fife\u00a0A, Deshpande\u00a0R, Baghai\u00a0M, Gunning\u00a0M, et al. Inception of the \u2018endocarditis team\u2019 is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a\u00a0before-and-after study. Open Heart. 2017;4(2):e699. https:\/\/doi.org\/10.1136\/openhrt-2017-000699.","journal-title":"Open Heart"},{"issue":"12","key":"1431_CR23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.297.12.1354","volume":"297","author":"A Wang","year":"2007","unstructured":"Wang\u00a0A, Athan\u00a0E, Pappas\u00a0PA, Fowler\u00a0VG Jr., Olaison\u00a0L, Pare\u00a0C, et\u00a0al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354\u201361.","journal-title":"JAMA"},{"issue":"4","key":"1431_CR24","doi-asserted-by":"crossref","first-page":"369.e1","DOI":"10.1016\/j.amjmed.2006.05.071","volume":"120","author":"JA San Roman","year":"2007","unstructured":"San Roman\u00a0JA, Lopez\u00a0J, Vilacosta\u00a0I, Luaces\u00a0M, Sarria\u00a0C, Revilla\u00a0A, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120(4):369.e1\u2013369.e7.","journal-title":"Am J Med"},{"issue":"12","key":"1431_CR25","doi-asserted-by":"crossref","first-page":"e82665","DOI":"10.1371\/journal.pone.0082665","volume":"8","author":"L Slipczuk","year":"2013","unstructured":"Slipczuk\u00a0L, Codolosa\u00a0JN, Davila\u00a0CD, Romero-Corral\u00a0A, Yun\u00a0J, Pressman\u00a0GS, et al. Infective endocarditis epidemiology over five decades: a\u00a0systematic review. PLoS One. 2013;8(12):e82665.","journal-title":"PLoS One"},{"issue":"39","key":"1431_CR26","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","volume":"40","author":"G Habib","year":"2019","unstructured":"Habib\u00a0G, Erba\u00a0PA, Iung\u00a0B, Donal\u00a0E, Cosyns\u00a0B, Laroche\u00a0C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a\u00a0prospective cohort study. Eur Heart\u00a0J. 2019;40(39):3222\u201332.","journal-title":"Eur Heart J"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-020-01431-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T19:49:47Z","timestamp":1622836187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-020-01431-z"}},"subtitle":["An analysis based on partial ESC EORP collected data"],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01431-z","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"5 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0El Kadi, D.M.F.\u00a0van den Buijs, T.\u00a0Meijers, M.D.\u00a0Gilbers, S.C.A.M.\u00a0Bekkers, J.\u00a0P.\u00a0van Melle, R.K.\u00a0Riezebos, W.L.\u00a0Blok, W.\u00a0Tanis, A.R.\u00a0Wahadat, J.W.\u00a0Roos-Hesselink, T.I.G.\u00a0van der Spoel, S.A.J.\u00a0Chamuleau and O.\u00a0Kamp declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}